title: A review of melatonin in hepatic ischemia/reperfusion injury and clinical liver disease.
abstract: Ischemia/reperfusion injury (IRI) can lead to cellular and, eventually, organ dysfunction, with the liver being one of the most frequently affected organs. Melatonin, a molecule that has notable antioxidant and anti-inflammatory properties, has been shown to protect against hepatic IRI. The purpose of this review is to summarize the protective effects of melatonin on hepatic IRI. The review initially summarizes the antioxidant properties of melatonin. We then discuss the protective effects of melatonin against endothelial and mitochondrial dysfunction. Thereafter, we introduce some information covering melatonin-related signaling pathways, including heme oxygenase-1 (HO-1), toll-like receptor (TLR), c-Jun N-terminal kinase (JNK), and so on. Furthermore, the clinical application of melatonin to hepatic diseases is considered. Finally, the safety of melatonin is evaluated. Taken together, the information compiled in this review will serve as a comprehensive reference regarding the pharmacological benefits of melatonin on hepatic IRI, aid in the design of future experimental research, and promote melatonin as a new therapeutic target.
authors.affiliation: Department of Neurosurgery, Xijing Hospital, The Fourth Military Medical University , Xi'an , China.
authors.forename: Yue
authors.initials: Y
authors.lastname: Li
authors.forename: Yang
authors.initials: Y
authors.lastname: Yang
authors.forename: Yingtong
authors.initials: Y
authors.lastname: Feng
authors.forename: Juanjuan
authors.initials: J
authors.lastname: Yan
authors.forename: Chongxi
authors.initials: C
authors.lastname: Fan
authors.forename: Shuai
authors.initials: S
authors.lastname: Jiang
authors.forename: Yan
authors.initials: Y
authors.lastname: Qu
mesh_terms: D000975:Antioxidants / Q000378:metabolism* / Q000627:therapeutic use*; D004727:Endothelium / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000098:blood supply; D008107:Liver Diseases / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D008550:Melatonin / Q000378:metabolism* / Q000627:therapeutic use*; D008928:Mitochondria / Q000378:metabolism; D015427:Reperfusion Injury / Q000150:complications / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D000975:Antioxidants; D008550:Melatonin
keywords: Antioxidant; clinical liver disease; hepatic ischemia/reperfusion injury; melatonin